antibiotic resistance

antibiotic resistance, loss of susceptibility of bacteria to the killing (bacteriocidal) or growth-inhibiting (bacteriostatic) properties of an antibiotic agent. When a resistant strain of bacteria is the dominant strain in an infection, the infection may be untreatable and life-threatening. Examples of bacteria that are resistant to antibiotics include methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Enterococcus, and multidrug-resistant Mycobacterium tuberculosis (MDR-TB), which is resistant to two tuberculosis drugs, isoniazid and rifampicin. MDR-TB is particularly dangerous because it can give rise to extensively drug-resistant M. tuberculosis (XDR-TB), which requires aggressive treatment using a combination of five different drugs.

The potential for antibiotic resistance was recognized in the early 1940s, almost immediately after the first large-scale clinical applications of penicillin, the first antibiotic. Mass production of penicillin was part of the greater war effort of World War II, when the drug was used widely by military populations and by some small civilian populations. Along with penicillin’s effectiveness in the treatment of the wounded, the drug was lauded for lowering the rate of venereal disease among military personnel, since it was particularly potent against the bacterial organisms notorious for causing syphilis and gonorrhea. However, even before the war had ended, resistance to penicillin was already reported—first in 1940 by British biochemists Sir Ernst Boris Chain and Sir Edward Penley Abraham, who published a report about an enzyme capable of destroying penicillin, and again in 1944 by several scientists working independently, who reported a penicillin-inactivating enzyme that was secreted by certain bacteria. In the following decades, overuse and repeated exposure to antibiotic agents favoured the selection and replication of numerous strains of antibiotic-resistant bacteria.

Mechanisms of resistance

There are several genetic mechanisms by which resistance to antibiotics can develop in bacteria. These mechanisms give rise to resistance because they result in biochemical modifications that alter certain bacterial cell properties that normally render the cell sensitive to an antibiotic. Examples of biochemical modifications that lead to resistance include the production of enzymes that inactivate the drug; the alteration of the protein, enzyme, or receptor targeted by the drug; the activation of drug efflux pumps that deliberately remove the drug from the cell; and the alteration of cell-wall proteins that inhibit drug uptake.

Discover how ordinary objects work, and expand your understanding of the familiar.

SIGN UP

" height="20" alt="HEW Logo">

Thank you for signing up!"

Back to homepage

By clicking "Sign Up", you consent to the Britannica Privacy Policy and Terms of Use.

Britannica Quiz

A Visit with the Word Doctor: Medical Vocabulary Quiz

There are two important types of genetic mechanisms that can give rise to antibiotic resistance: mutation and acquisition of new genetic material. In the case of mutation, the rate at which resistance develops can be attributed to the rate at which bacteria mutate. A mutation is a permanent change in an organism’s genetic material. Mutations occur naturally when cells divide. Bacteria are especially prone to mutation because their genome consists of a single chromosome and because they have a high rate of replication. The more replications a cell undergoes, the higher the chance it has to mutate. The acquisition of new genetic material also is a naturally occurring process in bacteria. This process appears to be the most common mechanism by which resistance develops; it is facilitated by the fact that bacteria are prokaryotic organisms (which means that they do not have a nucleus protecting the genome) and by the presence of small pieces of DNA called plasmids that exist in a bacterial cell separate from the chromosome. Thus, the genetic material of bacteria is free-floating within the cell, making it open to gene transfer (the movement of a segment of genetic material from one bacterial cell to another), which often involves the transmission of plasmids.

In nature, the primary mechanisms of bacterial gene transfer are transduction and conjugation. Transduction occurs when a bacterial virus, called a bacteriophage, detaches from one bacterial cell, carrying with it some of that bacterium’s genome, and then infects another cell. When the bacteriophage inserts its genetic content into the genome of the next bacterium, the previous bacterium’s DNA also is incorporated into the genome. Conjugation occurs when two bacteria come into physical contact with each other and a plasmid, sometimes carrying a piece of the chromosomal DNA, is transferred from the donor cell to the recipient cell. Plasmids often carry genes encoding enzymes capable of inactivating certain antibiotics. The original source of the genes for these enzymes is not known with certainty; however, mobile genetic elements, called transposons (“jumping” genes), may have played a role in their appearance and may facilitate their transfer to other bacterial species. Because many of the plasmids carrying antibiotic-resistant genes can be transferred between different species of bacteria, widespread resistance to a specific antibiotic can develop rapidly.

The transmission of plasmids during conjugation has been associated with the generation of many different types of antibiotic-resistant bacteria. For example, conjugation involving a plasmid carrying the gene for resistance to methicillin (an antibiotic derived from penicillin) is suspected to have resulted in the generation of MRSA. Penicillin and methicillin work by weakening the wall of the bacterial cell; when the wall is compromised, the osmotic gradient between a bacterial cell’s cytoplasm and its environment forces the cell to lyse (break open). In MRSA the gene acquired through conjugation encodes a protein capable of inhibiting methicillin binding, preventing the drug from attaching to and disrupting its target protein in the bacterial cell wall. Another example is a plasmid carrying a gene that encodes the enzyme beta-lactamase. Beta-lactamase alters the structure of the penicillin molecule, rendering it inactive.

Transduction and conjugation result in a process called recombination. The new bacterial genomes that are produced from genetic recombination are called recombinants. Antibiotics do not create recombinants—antibiotic-resistant recombinants exist naturally by way of normal gene transfer events. However, antibiotics, and particularly the improper use of these drugs, provide selective pressure to bacterial colonies, whereby the most sensitive organisms are killed quickly, and the most resistant organisms are able to survive and replicate.

Explore Britannica Premium!

The trusted destination for professionals, college students, and lifelong learners.

SUBSCRIBE

Prevention and drug development

The prospects of scientists developing new antibiotics as fast as bacteria develop resistance are poor. Therefore, other measures have been undertaken, including educating the public about the proper use of antibiotics and the importance of completing a full regimen as prescribed. Improvements in diagnostic equipment to facilitate the isolation and detection of resistant bacteria such as MRSA in hospital settings have enabled rapid identification of these organisms within hours rather than days or weeks. In addition, although efforts to fight bacteria by targeting them with bacteriophages were largely abandoned with the discovery of penicillin and broad-spectrum antibiotics in the 1940s, the growing presence of resistance has renewed interest in these methods. In addition, a significant amount of phage-therapy research was conducted throughout the 20th century in regions within the former Soviet Union. As a result, today in Georgia, which was once under Soviet rule, bandages saturated with bacteriophages against staphylococcus are commercially available as topical treatments for wounds and burns. In the 21st century, researchers worldwide were working to develop other topical and systemic phage therapies.

A practical and extremely effective tool against the spread of antibiotic resistance is hand washing. The importance of hand washing was first realized in the 1840s by German-Hungarian physician Ignaz Philipp Semmelweis. Today, hand washing among medical personnel still is not as routine and thorough as it should be. In the early 2000s American critical-care physician Peter Pronovost developed a checklist for intensive care units that attending personnel could follow to ensure that every hand washing, antiseptic scrub, and surface disinfection required during medical procedures was performed, in order to prevent the spread of infection to hospitalized patients. Hospitals that have adopted these methods have lost fewer patients to complications caused by bacterial infections.